Literature DB >> 8503256

Cytokine production by peripheral blood monocytes/macrophages in multiple sclerosis patients.

K Imamura1, A Suzumura, F Hayashi, T Marunouchi.   

Abstract

To determine the function of monocytes/macrophages in the acute phase of multiple sclerosis (MS), we investigated the production of tumor necrosis factor alpha (TNF alpha), interleukin-1 alpha (IL-1 alpha), IL-1 beta and IL-6 by peripheral blood monocytes/macrophages (PBM) in patients with MS, other autoimmune neurological disease (OAND), other neurological disease (OND) and normal controls was assessed using enzyme-linked immunosorbent assay (ELISA). When stimulated with lipopolysaccharide or phorbol ester, PBM obtained during acute phase of MS relapse patients produced significantly higher amounts of all these cytokines than did PBM from patients with chronic stable MS or OAND or OND or from normal controls. The results suggest a possible role of activated monocytes/macrophages in the acute exacerbation of MS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8503256     DOI: 10.1111/j.1600-0404.1993.tb05508.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  11 in total

1.  Correlation between interferon production and clinical disease activity in patients with multiple sclerosis.

Authors:  M Dettke; P Scheidt; H Prange; H Kirchner
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

2.  Patterns of disease activity in multiple sclerosis patients: a study with quantitative gadolinium-enhanced brain MRI and cytokine measurement in different clinical subgroups.

Authors:  M Rovaris; D Barnes; N Woodrofe; G H du Boulay; J W Thorpe; A J Thompson; W I McDonald; D H Miller
Journal:  J Neurol       Date:  1996-07       Impact factor: 4.849

3.  Association of interleukin-1 gene polymorphisms with multiple sclerosis: a meta-analysis.

Authors:  Jian Huang; Zi-Kang Xie; Rong-Bin Lu; Zheng-Fu Xie
Journal:  Inflamm Res       Date:  2012-10-04       Impact factor: 4.575

Review 4.  Differential contribution of microglia and monocytes in neurodegenerative diseases.

Authors:  Caroline Baufeld; Elaine O'Loughlin; Narghes Calcagno; Charlotte Madore; Oleg Butovsky
Journal:  J Neural Transm (Vienna)       Date:  2017-10-23       Impact factor: 3.575

5.  Detection of altered T helper 1 and T helper 2 cytokine production by peripheral blood mononuclear cells in patients with multiple sclerosis utilizing intracellular cytokine detection by flow cytometry and surface marker analysis.

Authors:  B Crucian; P Dunne; H Friedman; R Ragsdale; S Pross; R Widen
Journal:  Clin Diagn Lab Immunol       Date:  1996-07

6.  Alterations in peripheral blood mononuclear cell cytokine production in response to phytohemagglutinin in multiple sclerosis patients.

Authors:  B Crucian; P Dunne; H Friedman; R Ragsdale; S Pross; R Widen
Journal:  Clin Diagn Lab Immunol       Date:  1995-11

7.  Single nucleotide polymorphisms in inflammatory genes and the risk of early onset of lone atrial fibrillation.

Authors:  Kristoffer M A Henningsen; Morten S Olesen; Maria Pedersen; Lone Nielsen; Stig Haunsø; Helle Bruunsgaard; Jesper Hastrup Svendsen
Journal:  Inflamm Res       Date:  2010-05-20       Impact factor: 4.575

8.  Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis.

Authors:  T Vartanian; Y Li; M Zhao; K Stefansson
Journal:  Mol Med       Date:  1995-11       Impact factor: 6.354

Review 9.  Much More than M1 and M2 Macrophages, There are also CD169(+) and TCR(+) Macrophages.

Authors:  Leslie Chávez-Galán; Maria L Olleros; Dominique Vesin; Irene Garcia
Journal:  Front Immunol       Date:  2015-05-26       Impact factor: 7.561

10.  Baseline gene expression signatures in monocytes from multiple sclerosis patients treated with interferon-beta.

Authors:  Marta F Bustamante; Ramil N Nurtdinov; Jordi Río; Xavier Montalban; Manuel Comabella
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.